Bio-techne TECH 深 沪
等待开盘 12-18 09:30:00 美东时间
57.21
-0.230
-0.40%
华盛通- 最 高58.28
- 今 开57.36
- 成交量 74.57万股
- 最 低 57.06
- 昨 收 57.44
- 总市值 89.25亿
- 52周最高 78.96
- 市盈率 静 124.56
- 换手率 0.48%
- 52周最低 45.77
- 委 比 -12.36%
- 总股本 1.56亿
- 历史最高 134.6025
- 量 比 0.50
- 振 幅 2.12%
- 历史最低 11.7725
- 每 手 1
- 风险率 8.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bio-Techne Announces Expanded Launch And First Shipment Of Its Next-Gen Leo System, Powered By Simple Western Technology
Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexing Enables up to 24 targets per sample and supports complex assay
12-09 19:32
Bio-Techne to Present at Upcoming Investor Conferences
MINNEAPOLIS, Nov. 25, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 8th Annual Evercore Healthcare Co...
11-25 20:00
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
11-21 15:50
Argus Research Maintains Buy on Bio-Techne, Raises Price Target to $68
Argus Research analyst David Toung maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $65 to $68.
11-20 22:13
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Wells Fargo Maintains Overweight on Bio-Techne, Raises Price Target to $70
Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and raises the price target from $59 to $70.
11-06 23:47
Bio-Techne shares are trading lower after the company reported worse-than-expected Q1 sales results.
Bio-Techne shares are trading lower after the company reported worse-than-expec...
11-05 22:04
Bio-Techne Q1 Adj. EPS $0.42, Inline, Sales $286.555M Miss $290.867M Estimate
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $286.555
11-05 19:31
BIO-TECHNE DECLARES DIVIDEND
MINNEAPOLIS, Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended S...
11-05 19:30
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
